Javascript must be enabled to continue!
Development of Fluorescently Labeled Self-Emulsifying Drug Delivery Systems (SEDDS) for Prolonged Stability, In Vitro Sustained Release, and Cellular Uptake
View through CrossRef
Aim:
In this study, four fluorescein hydrophobic ionic complexes were formed with the
cationic polymers Eudragit RS, Eudragit RL, Eudragit E, and polyethyleneimine (PEI) to provide
fluorescein sustained release, sustained cellular uptake, and stability.
Methods:
Complexes were loaded in a self-emulsifying drug delivery system (SEDDS) composed
of 40% Tween 80, 20% Kolliphor EL, 15% 2-n-Octyl-1-dodecanol, and 25% dipropylene glycol.
SEDDS were investigated regarding their size, polydispersity index (PDI), zeta potential, and cytotoxicity.
Fluorescein release from SEDDS was performed in phosphate buffer (pH 6.8 and pH 8),
and the released fluorescein was evaluated for cellular uptake. Moreover, fluorescein from all of
the SEDDS pre-concentrates was released at different time points to check its long-term stability
over six months.
Results:
The average fluorescein load in SEDDS was 0.045%. SEDDS showed an average droplet
size of 24.9 ± 1.6 nm with PDI ≤ 0.3. SEDDS complexes diluted 1:100 increased the zeta potential
from -7.3 mV to +3.7 mV and provided > 85% cell viability. A 92.27 ± 3.18% fluorescein exhibited
a few seconds of immediate release when used as control or PEI complex in SEDDS. On the
contrary, Eudragit-fluorescein complexes in SEDDS showed sustained release of 87.01 ± 5.22%
fluorescein in ≤ 70 min with 22.19 ± 14.56% and 59.27 ± 16.57% released at 10 min in pH 6.8 and
pH 8 release media, respectively. Comparatively, the medium at pH 6.8 maintained a significantly
improved sustained fluorescein release (p ≤ 0.001). Furthermore, Eudragit RS/RL compared to
Eudragit E, significantly exhibited a slower fluorescein release rate from SEDDS (p ≤ 0.01). The
cellular uptake of the released fluorescein was 72.4 ± 8.2% for all SEDDS complexes after 3 h.
Eudragit complexes compared to PEI complex in SEDDS significantly showed m ore sustained
fluorescein cellular uptake at 1 h and 2 h (p ≤ 0.001). However, SEDDS complexes showed the
longest fluorescein stability with PEI after six months, whereas fluorescein stability for SEDDS
containing fluorescein as Eudragit complex and control showed 39.1% and 82.5% fluorescence
decrease, respectively, after three months.
Conclusion:
In the developed SEDDS, the presence of hydrophobic ionic complexes can significantly
promote longer stability and sustained cellular uptake of fluorescein while releasing in a
sustained manner.
Bentham Science Publishers Ltd.
Title: Development of Fluorescently Labeled Self-Emulsifying Drug Delivery
Systems (SEDDS) for Prolonged Stability, In Vitro Sustained Release, and
Cellular Uptake
Description:
Aim:
In this study, four fluorescein hydrophobic ionic complexes were formed with the
cationic polymers Eudragit RS, Eudragit RL, Eudragit E, and polyethyleneimine (PEI) to provide
fluorescein sustained release, sustained cellular uptake, and stability.
Methods:
Complexes were loaded in a self-emulsifying drug delivery system (SEDDS) composed
of 40% Tween 80, 20% Kolliphor EL, 15% 2-n-Octyl-1-dodecanol, and 25% dipropylene glycol.
SEDDS were investigated regarding their size, polydispersity index (PDI), zeta potential, and cytotoxicity.
Fluorescein release from SEDDS was performed in phosphate buffer (pH 6.
8 and pH 8),
and the released fluorescein was evaluated for cellular uptake.
Moreover, fluorescein from all of
the SEDDS pre-concentrates was released at different time points to check its long-term stability
over six months.
Results:
The average fluorescein load in SEDDS was 0.
045%.
SEDDS showed an average droplet
size of 24.
9 ± 1.
6 nm with PDI ≤ 0.
3.
SEDDS complexes diluted 1:100 increased the zeta potential
from -7.
3 mV to +3.
7 mV and provided > 85% cell viability.
A 92.
27 ± 3.
18% fluorescein exhibited
a few seconds of immediate release when used as control or PEI complex in SEDDS.
On the
contrary, Eudragit-fluorescein complexes in SEDDS showed sustained release of 87.
01 ± 5.
22%
fluorescein in ≤ 70 min with 22.
19 ± 14.
56% and 59.
27 ± 16.
57% released at 10 min in pH 6.
8 and
pH 8 release media, respectively.
Comparatively, the medium at pH 6.
8 maintained a significantly
improved sustained fluorescein release (p ≤ 0.
001).
Furthermore, Eudragit RS/RL compared to
Eudragit E, significantly exhibited a slower fluorescein release rate from SEDDS (p ≤ 0.
01).
The
cellular uptake of the released fluorescein was 72.
4 ± 8.
2% for all SEDDS complexes after 3 h.
Eudragit complexes compared to PEI complex in SEDDS significantly showed m ore sustained
fluorescein cellular uptake at 1 h and 2 h (p ≤ 0.
001).
However, SEDDS complexes showed the
longest fluorescein stability with PEI after six months, whereas fluorescein stability for SEDDS
containing fluorescein as Eudragit complex and control showed 39.
1% and 82.
5% fluorescence
decrease, respectively, after three months.
Conclusion:
In the developed SEDDS, the presence of hydrophobic ionic complexes can significantly
promote longer stability and sustained cellular uptake of fluorescein while releasing in a
sustained manner.
Related Results
Abstract 3029: A modular lipid-based oral drug delivery system for precision combination chemotherapy in breast cancer
Abstract 3029: A modular lipid-based oral drug delivery system for precision combination chemotherapy in breast cancer
Abstract
Breast cancer is the third leading cause of cancer-related deaths among women in the United States. Treatment o...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Development and Evaluation of Liquid and Solid Self-Emulsifying Drug Delivery Systems for Atorvastatin
Development and Evaluation of Liquid and Solid Self-Emulsifying Drug Delivery Systems for Atorvastatin
The objective of this work was to design and characterize liquid and solid self-emulsifying drug delivery systems (SEDDS) for poorly soluble atorvastatin. To optimize the compositi...
The Technology of Self-Emulsifying Drug Delivery Systems
The Technology of Self-Emulsifying Drug Delivery Systems
Nearly 40% of novel chemical entities show evidence of low solubility in water and low bioavailability. Self-emulsifying formulations have showed the power to improve the bioavaila...
REVIEW STUDY ON ANALYSIS OF THE SOLUBILITY OF BIOPHARMACEUTICAL CLASSIFICATION SYSTEM CLASS II DRUGS IN A SELF-EMULSIFYING DRUG DELIVERY SYSTEM
REVIEW STUDY ON ANALYSIS OF THE SOLUBILITY OF BIOPHARMACEUTICAL CLASSIFICATION SYSTEM CLASS II DRUGS IN A SELF-EMULSIFYING DRUG DELIVERY SYSTEM
By dissolving drug molecules in these solutions, a unit dosage form for oral administration can be generated for oral administration. Self-emulsifying drug delivery system (SEDDS) ...
Preparation of Solid Self-Emulsifying Drug Delivery System of Manidipine Hydrochloride
Preparation of Solid Self-Emulsifying Drug Delivery System of Manidipine Hydrochloride
The ability of self-emulsifying drug delivery system (SEDDS), which is a mixture of oils, surfactants and co-surfactants, to improve dissolution rate of a poorly water-soluble drug...
Review article on self emulsifying system
Review article on self emulsifying system
The solubility challenges faced by the pharmaceutical industry, particularly with orally administered drugs, are indeed significant. Low aqueous solubility often leads to poor diss...
Enhanced Intestinal Permeability of Cefixime by Self-Emulsifying Drug Delivery System: In-Vitro and Ex-Vivo Characterization
Enhanced Intestinal Permeability of Cefixime by Self-Emulsifying Drug Delivery System: In-Vitro and Ex-Vivo Characterization
Background: Cefixime (CFX) belongs to a group of third-generation cephalosporin antibiotics with low water solubility and low intestinal permeability, which ultimately leads to sig...

